PTC Therapeutics
PTCT
PTCT
202 hedge funds and large institutions have $3.47B invested in PTC Therapeutics in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.74% more ownership
Funds ownership: 102.7% → 103.44% (+0.74%)
0% more funds holding
Funds holding: 202 → 202 (0)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
202
Holding in Top 10
6
Calls
$34.6M
Puts
$15.8M
Top Buyers
| 1 | +$92.2M | |
| 2 | +$90.6M | |
| 3 | +$41.2M | |
| 4 |
BlackRock
New York
|
+$27.4M |
| 5 |
BAMCO Inc
New York
|
+$25.7M |
Top Sellers
| 1 | -$72.7M | |
| 2 | -$51.2M | |
| 3 | -$44.4M | |
| 4 |
Renaissance Technologies
New York
|
-$19M |
| 5 |
Two Sigma Investments
New York
|
-$8.15M |